Norepinephrine Regulates Condylar Bone Loss via Comorbid Factors

Area of Science:

• Orthopedics
• Neuroscience
• Dental Science

Background:

• Temporomandibular disorders (TMD) frequently involve degenerative changes in condylar subchondral bone.
• Psychological stress and occlusal abnormalities are implicated in TMD, but their synergistic role in sympathetic nervous system-regulated bone degradation is unclear.

Purpose of the Study:

• To investigate the synergistic effects of chronic immobilization stress (CIS) and unilateral anterior crossbite (UAC) on condylar subchondral bone degradation.
• To determine the role of the sympathetic nervous system, specifically norepinephrine, in these degenerative processes.

Main Methods:

• A murine model was used, with sequential application of CIS, chemical sympathectomy, and UAC.
• Norepinephrine levels in serum and condylar subchondral bone were measured using ELISA.
• Bone and cartilage remodeling parameters, including gene expression, were analyzed.

Main Results:

• Both CIS and UAC led to subchondral bone loss and increased norepinephrine levels.
• Combined CIS + UAC exacerbated bone loss, increased norepinephrine, and reduced cartilage thickness compared to individual stressors.
• Sympathectomy prevented bone loss and reduced norepinephrine levels, while norepinephrine exposure in vitro decreased bone formation markers and increased resorption markers.

Conclusions:

• CIS and UAC synergistically promote condylar subchondral bone loss and cartilage degradation.
• Norepinephrine within the subchondral bone plays a partial regulatory role in these stress- and occlusion-induced degenerative changes.